AAN: Higher fitness level tied to lower Alzheimer’s disease risk
Feb 28, 2022
A graded association was seen between levels of cardiorespiratory fitness and the incidence of Alzheimer’s disease and related disorders.
California continues investment in aging services, workforce development
By
Kimberly Bonvissuto
Jan 25, 2022
As California celebrates the first anniversary of its Master Plan for Aging, Gov. Gavin Newsom (D) released his 2022-23 budget proposal to make additional investments in aging priorities, including supporting...
SAGE detects conversion from mild cognitive impairment to dementia early
Dec 23, 2021
The Self-Administered Gerocognitive Examination detects the conversion from mild cognitive impairment to dementia sooner than the non-self-administered Mini-Mental State Examination.
Higher resting heart rate tied to dementia risk in older adults
Dec 15, 2021
An elevated resting heart rate also was associated with accelerated cognitive decline.
More news for Tuesday, Nov. 30
By
Amy Novotney
Nov 30, 2021
Assisted living provider sued for alleged neglect of memory care resident … Senior living firm charged with false advertising and gross negligence after resident’s death … Health officials close...
Trial begins of nasal vaccine for Alzheimer’s disease
Nov 18, 2021
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
Mirtazapine does not reduce agitation in dementia patients
Nov 03, 2021
In a randomized, double-blind trial, no difference was seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo.
ADHD linked to Alzheimer’s disease across generations
Sep 13, 2021
The risk for Alzheimer’s disease increased for parents of individuals with ADHD; the associations were attenuated with decreasing genetic relatedness.
A wandering solution for home care patients with dementia
By
Caroline Szachnowski
Aug 16, 2021
Project Lifesaver, a program from the Alzheimer’s Disease Caregiver Support Initiative, is designed to help caregivers keep track of their loved ones and locate them if they wander.
House committees to investigate new Alzheimer’s disease drug approval
Jul 01, 2021
The FDA approved aducanumab earlier this month, despite advisory committee’s conclusion that there was not enough evidence to support its effectiveness.